<DOC>
	<DOCNO>NCT01719055</DOCNO>
	<brief_summary>To compile characteristic real-world clinical outcome Boston Scientific commercially approve neurostimulation system pain routine clinical practice , use accord applicable Directions Use - - To evaluate economic value technical performance Boston Scientific commercially approve neurostimulation system pain routine clinical practice</brief_summary>
	<brief_title>RELIEF - A Global Registry Evaluate Long-Term Effectiveness Neurostimulation Therapy Pain</brief_title>
	<detailed_description>The study prospective , multi-center , global registry Boston Scientific neurostimulation system pain . The study treatment consist neurostimulation trial therapy commercially approve Boston Scientific Corporation neurostimulator pain . Positive trial , subject successful trial outcome , may progress permanent implant neurostimulation system . Individualization neurostimulation therapy pain determine accord investigator discretion site routine care , accordance inclusion exclusion criterion .</detailed_description>
	<criteria>Key Study candidate schedule trialed , onlabel , commercially approve Boston Scientific neurostimulation system pain , per local direction use Signed valid , IRB/ECapproved inform consent form 18 year age old Key Contraindicated Boston Scientific neurostimulation system Currently diagnose cognitive impairment , exhibit characteristic , would limit study candidate 's ability ass pain relief complete study assessment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>stimulation</keyword>
	<keyword>implantable</keyword>
	<keyword>pulse generator</keyword>
	<keyword>back pain</keyword>
	<keyword>chronic pain</keyword>
	<keyword>leg pain</keyword>
</DOC>